MetaADEDB 2.0 @ LMMD
Oxycodone and acetaminophen
(RJEIGSKSSKIIHG-RKXJKUSZSA-N)
Structure
SMILES
CC(=O)Nc1ccc(cc1)O.COc1ccc2c3c1O[C@@H]1[C@@]43CCN([C@H](C2)[C@]4(O)CCC1=O)C
Molecular Formula:
C26H30N2O6
Molecular Weight:
466.526
Log P:
2.4097
Hydrogen Bond Acceptor:
8
Hydrogen Bond Donor:
3
TPSA:
108.33
CAS Number(s):
330988-72-2
Synonym(s)
1.
Oxycodone and acetaminophen
External Link(s)
PubChem Compound11993742
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Drug ineffectiveFAERS: 219
Canada Vigilance: 22
Canada Vigilance
US FAERS
2NauseaFAERS: 72
Canada Vigilance: 16
Canada Vigilance
US FAERS
3HeadacheFAERS: 49
Canada Vigilance: 2
Canada Vigilance
US FAERS
4MalaiseFAERS: 33US FAERS
5VomitingFAERS: 32
Canada Vigilance: 7
Canada Vigilance
US FAERS
6Product substitution issueFAERS: 31US FAERS
7Abdominal discomfortFAERS: 25
Canada Vigilance: 7
Canada Vigilance
US FAERS
8PruritusFAERS: 21
Canada Vigilance: 4
Canada Vigilance
US FAERS
9Completed SuicideFAERS: 20US FAERS
10DizzinessFAERS: 19US FAERS
11PainFAERS: 18
Canada Vigilance: 4
Canada Vigilance
US FAERS
12Feeling abnormalFAERS: 16US FAERS
13Product quality issueFAERS: 15US FAERS
14Pharmaceutical product complaintFAERS: 13US FAERS
15SomnolenceFAERS: 13
Canada Vigilance: 1
Canada Vigilance
US FAERS
16Abdominal PainFAERS: 12
Canada Vigilance: 5
Canada Vigilance
US FAERS
17ConstipationFAERS: 12
Canada Vigilance: 2
Canada Vigilance
US FAERS
18Drug diversionFAERS: 12US FAERS
19AnxietyFAERS: 11US FAERS
20FatigueFAERS: 11US FAERS
21Chest PainFAERS: 10US FAERS
22Therapeutic response unexpected with drug substitutionFAERS: 10US FAERS
23TremorFAERS: 10US FAERS
24Drug abuseFAERS: 9US FAERS
25Adverse eventFAERS: 8US FAERS
26Cardiac ArrestFAERS: 8US FAERS
27Drug dispensing errorFAERS: 8US FAERS
28OverdoseFAERS: 7US FAERS
29Respiratory arrestFAERS: 7US FAERS
30Drug screen negativeFAERS: 6US FAERS
31Drug withdrawal syndromeFAERS: 6US FAERS
32TinnitusFAERS: 6US FAERS
33AstheniaFAERS: 5US FAERS
34Depressed Level of ConsciousnessFAERS: 5US FAERS
35DisorientationFAERS: 5US FAERS
36DysgeusiaFAERS: 5US FAERS
37FlatulenceFAERS: 5US FAERS
38HypersensitivityFAERS: 5US FAERS
39Inadequate analgesiaFAERS: 5US FAERS
40Incorrect dose administeredFAERS: 5US FAERS
41Intentional product misuseFAERS: 5US FAERS
42MyalgiaFAERS: 5US FAERS
43SwellingFAERS: 5US FAERS
44ArthralgiaFAERS: 4US FAERS
45Back PainFAERS: 4US FAERS
46ChillsFAERS: 4US FAERS
47ChromaturiaFAERS: 4US FAERS
48Drug DependenceFAERS: 4US FAERS
49Drug screen positiveFAERS: 4US FAERS
50DyspepsiaFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
51DysuriaFAERS: 4US FAERS
52ErythemaFAERS: 4US FAERS
53FlushingFAERS: 4US FAERS
54Intentional drug misuseFAERS: 4US FAERS
55Night sweatsFAERS: 4US FAERS
56PalpitationsFAERS: 4US FAERS
57Product formulation issueFAERS: 4US FAERS
58Rash erythematousFAERS: 4US FAERS
59Renal painFAERS: 4US FAERS
60Throat irritationFAERS: 4US FAERS
61Unevaluable eventFAERS: 4US FAERS
62UrticariaFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
63Activities of daily living impairedFAERS: 3US FAERS
64AgitationFAERS: 3US FAERS
65AngerFAERS: 3US FAERS
66Aspartate Aminotransferase IncreasedFAERS: 3US FAERS
67Brain DeathFAERS: 3US FAERS
68Chest discomfortFAERS: 3US FAERS
69Drug effect incompleteFAERS: 3US FAERS
70Emergency CareFAERS: 3US FAERS
71HepatotoxicityFAERS: 3US FAERS
72Inappropriate schedule of drug administrationFAERS: 3US FAERS
73Medication ErrorFAERS: 3US FAERS
74Mood swingsFAERS: 3US FAERS
75NasopharyngitisFAERS: 3US FAERS
76NervousnessFAERS: 3US FAERS
77Oropharyngeal painFAERS: 3US FAERS
78Product comminglingFAERS: 3US FAERS
79Product dispensing errorFAERS: 3US FAERS
80Reaction to excipientFAERS: 3US FAERS
81Tongue discomfortFAERS: 3US FAERS
82VertigoFAERS: 3US FAERS
83Visual ImpairmentFAERS: 3US FAERS
84Atrial FibrillationFAERS: 2US FAERS
85BedriddenFAERS: 2US FAERS
86CellulitisFAERS: 2US FAERS
87CryingFAERS: 2US FAERS
88Drug abuserFAERS: 2US FAERS
89Drug administration errorFAERS: 2US FAERS
90Drug ineffective for unapproved indicationFAERS: 2US FAERS
91Drug level decreasedFAERS: 2US FAERS
92EructationFAERS: 2US FAERS
93Feeling jitteryFAERS: 2US FAERS
94FormicationFAERS: 2US FAERS
95GastritisFAERS: 2US FAERS
96Gastrointestinal PainFAERS: 2US FAERS
97General physical health deteriorationFAERS: 2US FAERS
98HepatomegalyFAERS: 2US FAERS
99HypersomniaFAERS: 2US FAERS
100HypotensionFAERS: 2US FAERS
101Impaired driving abilityFAERS: 2US FAERS
102IncoherentFAERS: 2US FAERS
103Intentional product use issueFAERS: 2US FAERS
104Intercepted product dispensing errorFAERS: 2US FAERS
105Joint swellingFAERS: 2US FAERS
106Lip swellingFAERS: 2US FAERS
107Mental status changesFAERS: 2US FAERS
108Multiple drug overdose intentionalFAERS: 2US FAERS
109Myocardial InfarctionFAERS: 2US FAERS
110Neck PainFAERS: 2US FAERS
111NecrosisFAERS: 2US FAERS
112NephrolithiasisFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
113No adverse eventFAERS: 2US FAERS
114PallorFAERS: 2US FAERS
115PancreatitisFAERS: 2US FAERS
116Pharmaceutical product counterfeitFAERS: 2US FAERS
117PoisoningFAERS: 2US FAERS
118Product shape issueFAERS: 2US FAERS
119Reaction to drug excipientsFAERS: 2US FAERS
120Respiratory FailureFAERS: 2US FAERS
121RetchingFAERS: 2US FAERS
122Soft Tissue InfectionFAERS: 2US FAERS
123Soft tissue necrosisFAERS: 2US FAERS
124TachycardiaFAERS: 2US FAERS
125Unresponsive to stimuliFAERS: 2US FAERS
126Wrong technique in drug usage processFAERS: 2US FAERS
127Wrong technique in product usage processFAERS: 2US FAERS
128nervous system disorderFAERS: 2US FAERS
129AcidosisFAERS: 1US FAERS
130AcneFAERS: 1US FAERS
131Alanine Aminotransferase IncreasedFAERS: 1US FAERS
132AmnesiaFAERS: 1US FAERS
133Anal sphincter atonyFAERS: 1US FAERS
134Analgesic drug level increasedFAERS: 1US FAERS
135Anaphylactic shockFAERS: 1US FAERS
136Angina PectorisFAERS: 1US FAERS
137AngioedemaFAERS: 1US FAERS
138ApathyFAERS: 1US FAERS
139AphagiaFAERS: 1US FAERS
140Aphthous StomatitisFAERS: 1US FAERS
141Bed restFAERS: 1US FAERS
142BlepharospasmFAERS: 1US FAERS
143Bone painFAERS: 1US FAERS
144BunionFAERS: 1US FAERS
145Burning sensationFAERS: 1US FAERS
146Cardiac TamponadeFAERS: 1US FAERS
147Cerebral atrophyFAERS: 1US FAERS
148Cerebrovascular accidentFAERS: 1US FAERS
149Cervical myelopathyFAERS: 1US FAERS
150Cold sweatFAERS: 1US FAERS
151Coronary Artery DiseaseFAERS: 1US FAERS
152Cortisol increasedFAERS: 1US FAERS
153Dark circles under eyesFAERS: 1US FAERS
154DeliriumFAERS: 1US FAERS
155DependenceFAERS: 1US FAERS
156DermatomyositisFAERS: 1US FAERS
157DiverticulitisFAERS: 1US FAERS
158Drug ToleranceFAERS: 1US FAERS
159Drug dispensed to wrong patientFAERS: 1US FAERS
160Drug effect delayedFAERS: 1US FAERS
161Drug effect variableFAERS: 1US FAERS
162Drug level increasedFAERS: 1US FAERS
163Drug toxicityFAERS: 1US FAERS
164Electromechanical dissociationFAERS: 1US FAERS
165Emotional disorderFAERS: 1US FAERS
166Emotional distressFAERS: 1US FAERS
167Euphoric moodFAERS: 1US FAERS
168Expired drug administeredFAERS: 1US FAERS
169Expired product administeredFAERS: 1US FAERS
170Facial PainFAERS: 1US FAERS
171Feeling ColdFAERS: 1US FAERS
172Flank PainFAERS: 1US FAERS
173Foreign body in respiratory tractFAERS: 1US FAERS
174Fungal rhinitisFAERS: 1US FAERS
175Gait inabilityFAERS: 1US FAERS
176Gastric ulcerFAERS: 1US FAERS
177Gastrointestinal ulcerFAERS: 1US FAERS
178GlossitisFAERS: 1US FAERS
179HemiplegiaFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
180HepatosplenomegalyFAERS: 1US FAERS
181HypercapniaFAERS: 1US FAERS
182HyperchlorhydriaFAERS: 1US FAERS
183Hypoaesthesia facialFAERS: 1US FAERS
184Incorrect drug dosage form administeredFAERS: 1US FAERS
185Incorrect product storageFAERS: 1US FAERS
186Increased bronchial secretionFAERS: 1US FAERS
187Increased upper airway secretionFAERS: 1US FAERS
188InfluenzaFAERS: 1US FAERS
189Intentional misuseFAERS: 1US FAERS
190Intercepted drug dispensing errorFAERS: 1US FAERS
191Irritable Bowel SyndromeFAERS: 1US FAERS
192Lack of spontaneous speechFAERS: 1US FAERS
193LethargyFAERS: 1US FAERS
194LeukopeniaFAERS: 1US FAERS
195Loss of personal independence in daily activitiesFAERS: 1US FAERS
196Medication residue presentFAERS: 1US FAERS
197Memory impairmentFAERS: 1US FAERS
198Mental impairmentFAERS: 1US FAERS
199Metabolic acidosisFAERS: 1US FAERS
200Middle insomniaFAERS: 1US FAERS
201Multi-organ disorderFAERS: 1US FAERS
202Musculoskeletal stiffnessFAERS: 1US FAERS
203Nasal mucosal erosionFAERS: 1US FAERS
204Nonspecific reactionFAERS: 1US FAERS
205Occupational exposure to productFAERS: 1US FAERS
206Oral fungal infectionFAERS: 1US FAERS
207Oral painFAERS: 1US FAERS
208Partner stressFAERS: 1US FAERS
209Pericardial effusionFAERS: 1US FAERS
210Peripheral swellingFAERS: 1US FAERS
211Personality ChangeFAERS: 1US FAERS
212PetechiaeFAERS: 1US FAERS
213Post-Traumatic Stress DisorderFAERS: 1US FAERS
214Prescribed overdoseFAERS: 1US FAERS
215Prescription form tamperingFAERS: 1US FAERS
216Product packaging quantity issueFAERS: 1US FAERS
217Product physical consistency issueFAERS: 1US FAERS
218Product physical issueFAERS: 1US FAERS
219Product size issueFAERS: 1US FAERS
220Product solubility abnormalFAERS: 1US FAERS
221Product taste abnormalFAERS: 1US FAERS
222Product use in unapproved indicationFAERS: 1US FAERS
223QuadriparesisFAERS: 1US FAERS
224QuadriplegiaFAERS: 1US FAERS
225Respiratory DepressionFAERS: 1US FAERS
226Respiratory distressFAERS: 1US FAERS
227Restless Legs SyndromeFAERS: 1US FAERS
228RestlessnessFAERS: 1US FAERS
229RhabdomyolysisFAERS: 1US FAERS
230SepsisFAERS: 1US FAERS
231Septic ShockFAERS: 1US FAERS
232Similar reaction on previous exposure to drugFAERS: 1US FAERS
233Sinus TachycardiaFAERS: 1US FAERS
234Sleep TalkingFAERS: 1US FAERS
235Sleep disorder due to a general medical conditionFAERS: 1US FAERS
236SnoringFAERS: 1US FAERS
237SplenitisFAERS: 1US FAERS
238Spontaneous penile erectionFAERS: 1US FAERS
239StenosisFAERS: 1US FAERS
240StomatitisFAERS: 1US FAERS
241Sudden onset of sleepFAERS: 1US FAERS
242Suicide attemptFAERS: 1US FAERS
243SyncopeFAERS: 1US FAERS
244TachyphreniaFAERS: 1US FAERS
245Therapeutic product ineffectiveFAERS: 1US FAERS
246Therapeutic response unexpectedFAERS: 1US FAERS
247Thermal burnFAERS: 1US FAERS
248ThirstFAERS: 1US FAERS
249ThrombosisFAERS: 1US FAERS
250Tongue exfoliationFAERS: 1US FAERS
251Tooth ErosionFAERS: 1US FAERS
252Toxicity to various agentsFAERS: 1US FAERS
253Transaminases increasedFAERS: 1US FAERS
254Transcription medication errorFAERS: 1US FAERS
255Urinary tract infectionFAERS: 1US FAERS
256Weight decreasedFAERS: 1US FAERS
257furuncleFAERS: 1US FAERS
258jaundiceFAERS: 1US FAERS
259Back disorderCanada Vigilance: 1Canada Vigilance
260Rotator cuff syndromeCanada Vigilance: 1Canada Vigilance
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120240

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.